Cytek Biosciences (CTKB) Stock Analysis & Winston Score
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden pot
Winston Score: 23/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (6/30)
- Growth: Weak (3/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (8/15)
Key Facts
Price: $4.62
Market Cap: $597M
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ
